Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bertrand

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Scientific Reports|October 30, 2020
Empirical comparison of analytical approaches for identifying molecular HIV-1 clustersVlad Novitsky, Jon A Steingrimsson, Mark Howison, et al.
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
BMJ Open|April 22, 2022
Beyond HIV outbreaks: protocol, rationale and implementation of a prospective study quantifying the benefit of incorporating viral sequence clustering analysis into routine public health interventionsJon A Steingrimsson, John Fulton, Mark Howison, et al.
Open Forum Infectious Diseases|January 6, 2022
Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USAVlad Novitsky, Jon Steingrimsson, Fizza S Gillani, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Scientific Reports|January 7, 2015
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodentsGuy Griebel, Philippe Pichat, Sandra Beeské, et al.
Journal of Medicinal Chemistry|April 25, 2012
Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancersVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Journal of Medicinal Chemistry|November 5, 2014
SAR156497, an exquisitely selective inhibitor of aurora kinasesJean-Christophe Carry, François Clerc, Hervé Minoux, et al.
Nature Cancer|February 5, 2022
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationLan Wu, Edward Seung, Ling Xu, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Scientific Reports|October 30, 2020
Empirical comparison of analytical approaches for identifying molecular HIV-1 clustersVlad Novitsky, Jon A Steingrimsson, Mark Howison, et al.
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
BMJ Open|April 22, 2022
Beyond HIV outbreaks: protocol, rationale and implementation of a prospective study quantifying the benefit of incorporating viral sequence clustering analysis into routine public health interventionsJon A Steingrimsson, John Fulton, Mark Howison, et al.
Open Forum Infectious Diseases|January 6, 2022
Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USAVlad Novitsky, Jon Steingrimsson, Fizza S Gillani, et al.
Nature Medicine|September 11, 2019
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patientsAntonino Cassotta, Vincent Mikol, Thomas Bertrand, et al.
Scientific Reports|January 7, 2015
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodentsGuy Griebel, Philippe Pichat, Sandra Beeské, et al.
Journal of Medicinal Chemistry|April 25, 2012
Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancersVictor Certal, Frank Halley, Angela Virone-Oddos, et al.
Journal of Medicinal Chemistry|November 5, 2014
SAR156497, an exquisitely selective inhibitor of aurora kinasesJean-Christophe Carry, François Clerc, Hervé Minoux, et al.
Nature Cancer|February 5, 2022
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationLan Wu, Edward Seung, Ling Xu, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Pageof 8